1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. NOVO NORDISK - ADR
50.03 -3.91 (-7.25%)
65.7M

XNYS 30 Jul, 2025 5:30 PM (EDT)

CEO Appointment
Novo Nordisk names insider Maziar Doustdar as CEO after Wegovy sales slump in Q2 See details

Novo Nordisk - ADR RSI, Moving Averages, Technical Analysis MACD, MFI, Stochastic and Candlesticks

Novo Nordisk - ADR technical analysis - SMA, EMA, Price Change analysis, 52 Week high low, Beta and volume delivery analysis